What the MHRA review found

Not every change in mood is a drug effect. Equally, nobody should dismiss your experience because a regulator found no causal link. The MHRA's review did not support a causal association between the GLP-1 receptor agonists it assessed and suicidal or self-injurious thoughts, depression or related outcomes.

That finding describes the evidence available. It gives no reason to ignore your symptoms, and your own mental health still needs assessment. Tell your prescriber about changes in mood, anxiety, motivation or behaviour. Mention other medicines, sleep problems and big life events too.

Treatment changes familiar routines

Food may have been part of how you connect with people, comfort yourself or structure your day. A smaller appetite changes those routines, and you may find the change welcome, unsettling or both. Weight change also brings comments from others, worries about body image and pressure for every part of life to improve at once.

You are not expected to feel any particular way. You may welcome easier movement and still dislike remarks about your body. You may feel let down even after clinically meaningful progress. Raise these feelings at your review. They do not mean you are ungrateful or doing treatment wrong.

Practical support

Think about which routines still bring you company and enjoyment: seeing a friend, a hobby, gentle activity or a regular meal you still find comfortable. Tell your care team if a smaller appetite has narrowed your social life or if anxiety about food is growing. A GP or mental health professional can assess what support suits you.

Do not change psychiatric medicines yourself because your weight or appetite has changed. If vomiting or an oral medicine schedule makes you worry about taking them reliably, ask your prescriber or pharmacist for specific advice. Joined-up care matters most when several services are involved.

Act fast if symptoms get worse

Get urgent help if you feel at risk of harming yourself or cannot keep yourself safe. In the UK, call emergency services if you are in immediate danger. For urgent support, use an urgent mental health service or NHS 111. You do not have to prove your prescription caused the problem before you ask for help.

For symptoms short of an emergency, book a review. Explain when they started, how they affect your daily life and whether anything in your treatment has changed. You can also report a suspected side effect through the Yellow Card scheme. A report feeds into safety monitoring. It does not replace clinical care and does not prove cause on its own.

Keep treatment private and still get support

You decide how much to tell friends, colleagues or family about your treatment. One trusted person who knows when you might need support often helps, and your prescription need not become a public topic. If comments about your weight upset you, a simple boundary keeps conversations on other subjects.

Within healthcare, share accurate information about your medicines with the professionals who look after you. Keeping treatment private from acquaintances should never leave your clinicians without the facts they need to assess a new symptom.

Sources

Your own medicine leaflet and prescriber come first. A source from another country does not mean the same rule applies in the UK.

  1. MHRA review of GLP-1 medicines and suicidal or self-injurious thoughts gov.uk
  2. NICE NG197: Shared decision making nice.org.uk
  3. MHRA Yellow Card reporting forms yellowcard.mhra.gov.uk

Spotted something out of date? Report a mistake.